Glucagon Solution Stabilization via Acidic pH and Polyol

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current glucagon formulations for treating hypoglycemia are not liquid, ready-to-use, non-gelling, chemically stable, pump-able, fast-acting, and safe for long-term use, particularly in bi-hormonal pumps, which are essential for effective glucose regulation in Type-1 diabetes patients.

Innovation Solution

A glucagon solution composition comprising an anti-gelling polyol, an injectable acid, a stabilizing-salt, an antioxidant, and water, with a pH between 2 and 5, which prevents gelation and chemical degradation, making it suitable for injection and use in insulin pumps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If glucagon is dissolved in water at physiological pH, then it is initially soluble, but it aggregates to form a gel within hours

Engineering Contradiction:
Improvesolution stabilityVSAvoidgelation prevention
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by adjusting the pH to acidic conditions (pH 2.0-3.5) and incorporating specific excipients (glycerin, hydrochloric acid) to prevent gelation. This chemical parameter modification maintains glucagon in a soluble, non-gelled state suitable for injection while preserving its therapeutic activity.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If glucagon is stored in acidic solution, then it remains soluble, but it degrades rapidly into numerous degradation products

Engineering Contradiction:
Improvechemical stabilityVSAvoiddegradation prevention
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent employs a composite formulation comprising glucagon hydrochloride, glycerin, hydrochloric acid, and water. This composite system leverages the stabilizing effects of glycerin and the solubilizing effects of hydrochloric acid to create a formulation that maintains chemical stability while preventing degradation, resolving the contradiction between solubility and stability.

Inventive Principle:
Principle #40Composite materials

3Stability of the object's composition

If glucagon is provided as a dry lyophilized cake, then it remains chemically stable, but it requires a multiple-step reconstitution procedure

Engineering Contradiction:
Improvechemical stabilityVSAvoidadministration simplicity
Core Design Contradiction:
Stability of the object's compositionVSEase of operation

Solution Approach 1:

The patent applies preliminary action by pre-dissolving glucagon in an acidic glycerin solution during manufacturing to create a ready-to-use liquid formulation. This eliminates the need for reconstitution at the point of administration, allowing for immediate injection while maintaining chemical stability through the acidic environment and glycerin stabilization.

Inventive Principle:
Principle #10Preliminary action

4Ease of operation

If a ready-to-inject glucagon solution is developed, then administration is simplified, but it must be used immediately due to instability

Engineering Contradiction:
Improveready-to-use capabilityVSAvoidshelf life
Core Design Contradiction:
Ease of operationVSDuration of action of stationary object

Solution Approach 1:

The patent utilizes parameter changes by maintaining the solution at acidic pH (2.0-3.5) with glycerin as a stabilizing excipient. These parameter modifications extend the shelf life of the ready-to-inject solution while preserving its liquid, ready-to-use characteristics, allowing storage without precipitation or gelation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution is a clear, stable, and fast-acting glucagon formulation that maintains glucagon activity for extended periods, ensuring effective glucose regulation and safety for chronic use in bi-hormonal pumps.

Implementation Method 1

The gelled glucagon consists predominantly of β-sheets or fibrils that are induced by the molecule's hydrophobicity and the inter- and intra-chain hydrogen bond forming potential of the peptide

Methodology Applied
Scientific EffectHydrogen bonding:

Implementation Method 2

an antioxidant

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

Glucagon has an isoelectric point of 7.1 and is insoluble in water at a physiological pH (pH 4-8). At pH 3 or lower, it is initially soluble

Methodology Applied
Scientific EffectIsoelectric point: Isoelectric Focusing

Data Source

PatentEP3344231B1Stabilized glucagon solutions
Publication Date: 2022.04.13 LATITUDE PHARMACEUTICALS INC
  • EP3344231B1 patent drawingFigure 1
  • EP3344231B1 patent drawingFigure 2
  • EP3344231B1 patent drawingFigure 3

AI summary

This invention relates to ready-to-use and safe solution compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon, an acid, anti-gelling polyol, a stabilizing-salt, viscosity reducer and an antioxidant, have a final pH between about 2 and 5, and is gel-free, chemically-stable, and pump-able.